Evidence map›Paper›PMID 38698435›Full record

ArticleJournal of nanobiotechnology2024

Folding molecular origami from ribosomal RNA.

Anastasia Shapiro, Noah Joseph, Nadav Mellul, Almogit Abu-Horowitz, Boaz Mizrahi, Ido Bachelet

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anastasia ShapiroAugmanity Nano Ltd., 8 Hamada St., 7670308, Rehovot, Israel.
Noah JosephAugmanity Nano Ltd., 8 Hamada St., 7670308, Rehovot, Israel.
Nadav MellulAugmanity Nano Ltd., 8 Hamada St., 7670308, Rehovot, Israel.
Almogit Abu-HorowitzAugmanity Nano Ltd., 8 Hamada St., 7670308, Rehovot, Israel.
Boaz MizrahiTechnion, Faculty of Biotechnology and Food Engineering, 32000, Haifa, Israel.
Ido BacheletAugmanity Nano Ltd., 8 Hamada St., 7670308, Rehovot, Israel. dogbach@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 80 percent of the total RNA in cells is ribosomal RNA (rRNA), making it an abundant and inexpensive natural source of long, single-stranded nucleic acid, which could be used as raw material for the fabrication of molecular origami. In this study, we demonstrate efficient and robust construction of 2D and 3D origami nanostructures utilizing cellular rRNA as a scaffold and DNA oligonucleotide staples. We present calibrated protocols for the robust folding of contiguous shapes from one or two rRNA subunits that are efficient to allow folding using crude extracts of total RNA. We also show that RNA maintains stability within the folded structure. Lastly, we present a novel and comprehensive analysis and insights into the stability of RNA:DNA origami nanostructures and demonstrate their enhanced stability when coated with polylysine-polyethylene glycol in different temperatures, low Mg

Indexed as

NanostructuresNucleic Acid ConformationRNA, RibosomalDNAHumansPolyethylene GlycolsPolylysineRNA FoldingDNAPolyethylene GlycolsPolylysineRNA, RibosomalHybrid origami structuresMolecular origami stabilityNanostructuresPolyethylene glycol (PEG) coatingRNA/DNA nanotechnologyRNA origami

Identifiers

PMID38698435
PMCPMC11067225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.